LiveActive security incident?Get immediate response
CVE Record

CVE-2023-38954: ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

UnknownCVSS not scoredNot KEV-listedUpdated
Discuss exposureBack to CVEs
Glexia's TakeAutomated analysisunknown

Security readout for executives and security teams

Plain-English summary

CVE-2023-38954 is a reported SQL injection vulnerability in ZKTeco BioAccess IVS v3.3.1. The public source bundle is sparse: it names the issue but does not provide severity, exploitability, affected-version range, or remediation details.

Executive priority

Treat this as a targeted exposure-management item, not a confirmed emergency. Prioritize discovery and vendor confirmation because access-control systems may be business-sensitive and the public record lacks remediation details.

Technical view

The CVE record describes SQL injection in ZKTeco BioAccess IVS v3.3.1. The provided sources do not identify the vulnerable endpoint, authentication requirement, CVSS score, CWE, exploit status, impact boundaries, or fixed release.

Likely exposure

Likely exposure is limited to organizations running ZKTeco BioAccess IVS v3.3.1. The bundle does not identify other affected versions, required configuration, or whether internet-facing deployments are specifically at risk.

Exploitation context

The source bundle does not show active exploitation, and KEV is false. SQL injection can be serious, but the available evidence is insufficient to confirm exploit maturity, attacker prerequisites, or operational impact.

Researcher notes

Evidence is incomplete. The CVE and Claroty reference identify SQL injection in BioAccess IVS v3.3.1, but do not provide technical indicators, affected endpoints, proof-of-concept status, or patch metadata in the supplied bundle.

Mitigation direction

  • Inventory BioAccess IVS deployments and identify any v3.3.1 instances.
  • Check ZKTeco and Claroty guidance for patches, upgrades, or workarounds.
  • Restrict administrative and application access to trusted networks only.
  • Review logs for unusual database errors or unexpected application behavior.

Validation and detection

  • Confirm whether BioAccess IVS v3.3.1 is present in the environment.
  • Record network exposure, authentication controls, and business role for each instance.
  • Check vendor release notes or support channels for fixed versions.
  • Validate compensating controls without attempting exploitation.
Prepared
Confidence
medium
Sources
3

Public sources used

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

description · low confidence lookup

Database behavior lookup

The CVE wording references database injection or access, so collection and exfiltration review may help. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2023-38954 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
3Timeline events
2ADP providers
2Source links

SSVC decision data

CISA-ADPCISA Coordinator
Timestamp
Version
2.0.3
Exploitation: noneAutomatable: yesTechnical Impact: total

Vulnerability timeline

Timeline events are normalized from CVE metadata, CNA source timelines, ADP timelines, and KEV metadata when present.

  1. CVE reservedCVE Program

    The CVE ID was reserved by the assigning CNA.

  2. CVE publishedCVE Program

    The CVE record was published.

  3. CVE updatedCVE Program

    The CVE record metadata indicates this as the latest update time.

ADP provider summaries

CVECVE Program Container
CISA-ADPCISA ADP Vulnrichment
other:ssvc

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.